Why the study?
Incidental pulmonary embolism is frequently detected on cancer staging or evaluation CT scans, but its optimal management remains unknown.
Does anticoagulation improve survival in cancer patients with incidental pulmonary embolism?
Population
703 cancer patients with newly diagnosed PE (including 474 with incidental PE)
Comparison
Anticoagulation therapy vs no anticoagulation therapy
Design
Retrospective cohort study
Authors
Loading...
Anticoagulation showed no survival benefit for distal IPE in cancer; leaves open optimal management pending randomized trials.
Does anticoagulation improve survival in cancer patients with incidental pulmonary embolism?
Anticoagulation provides a survival benefit for cancer patients with proximal incidental pulmonary embolism, but may not be necessary for those with distal incidental pulmonary embolism.
Chang et al. (2019) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: